<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35522207</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1744-5078</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>06</Day>
            </PubDate>
          </JournalIssue>
          <Title>Ocular immunology and inflammation</Title>
          <ISOAbbreviation>Ocul Immunol Inflamm</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Clinical Profile of Scleritis Presenting for the First Time in the Elderly.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>5</EndPage>
          <MedlinePgn>1-5</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/09273948.2022.2046792</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">To analyze clinical characteristics of scleritis in elderly patients and also compare the data with relatively younger patients with scleritis (&lt;60 years).</AbstractText>
          <AbstractText Label="METHOD" NlmCategory="UNASSIGNED">Retrospective analysis of medical records of patients with scleritis who visited a tertiary eye care centre between 2008 and 2018.</AbstractText>
          <AbstractText Label="RESULT" NlmCategory="UNASSIGNED">Scleritis in ≥60 years accounted for 3% of the total scleritis cases. The mean age of the patients was 67 ± 6 years, and a female (66%) predominance was noted. Of the 44 elderly patients with scleritis, 48% were 66-70 years of age and 20% were above 70 years of age. Diffuse scleritis was the most common subtypes followed by necrotizing scleritis (35%). Overall, 32% of elderly patients with scleritis had underlying disease and the most common systemic association was granulomatous with polyangiitis. When compared with a subset of patients (&lt;60 years of age), the elderly group showed higher rate of recurrences and complications.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Scleritis in elderly patients is relatively rare but can have a higher recurrence rate with a increased complications.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Magesan</LastName>
            <ForeName>Kowsigan</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Medical research foundation, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Surya</LastName>
            <ForeName>Janani</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Biostatistics, Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sridharan</LastName>
            <ForeName>Sudharshan</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nair</LastName>
            <ForeName>Vineeta</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agarwal</LastName>
            <ForeName>Mamta</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0001-9695-0868</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Agarwal</LastName>
            <ForeName>Amala Elizabeth</ForeName>
            <Initials>AE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Biswas</LastName>
            <ForeName>Jyotirmay</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Uvea, Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dutta Majumder</LastName>
            <ForeName>Parthopratim</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Medical and Vision Research Foundations, Sankara Nethralaya, Chennai, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Ocul Immunol Inflamm</MedlineTA>
        <NlmUniqueID>9312169</NlmUniqueID>
        <ISSNLinking>0927-3948</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Corticosteroid</Keyword>
        <Keyword MajorTopicYN="N">Scleritis</Keyword>
        <Keyword MajorTopicYN="N">granulomatosis polyangitis</Keyword>
        <Keyword MajorTopicYN="N">necrotizing scleritis</Keyword>
        <Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>10</Hour>
          <Minute>53</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35522207</ArticleId>
        <ArticleId IdType="doi">10.1080/09273948.2022.2046792</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
